Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Tissue Regenix Group (TRX) Regulatory News

Date Source Headline
4th Jun 2019 7:00 am RNS Secures Credit Facilities of up to $20m
4th Jun 2019 7:00 am RNS Annual Results for the year ended 31 December 2018
21st May 2019 7:00 am RNS CEO to return to full time duties
10th Apr 2019 7:20 am EQS Hardman & Co Research: Tissue Regenix (TRX): Expanded GPO coverage secured
4th Apr 2019 7:26 am RNS Expands US GPO coverage for DermaPure
18th Feb 2019 7:00 am RNS Change of Adviser
6th Feb 2019 11:05 am RNS Second Price Monitoring Extn
6th Feb 2019 11:00 am RNS Price Monitoring Extension
4th Feb 2019 7:00 am RNS Trading Update
17th Dec 2018 11:56 am EQS Hardman & Co Research: Tissue Regenix (TRX): 2018 in review: foundations laid for osteobiologics
6th Dec 2018 7:00 am RNS Interim Management Change
13th Nov 2018 7:00 am RNS Pan European distribution agreement with Arthrex
29th Oct 2018 7:00 am RNS Gareth Jones commences position as CFO
14th Sep 2018 7:16 am EQS Hardman & Co Research: Tissue Regenix (TRX): Strategy delivering growth above expectations
3rd Sep 2018 7:00 am RNS Unaudited Interim Results
2nd Aug 2018 10:10 am EQS Hardman & Co Research: Tissue Regenix (TRX): 1H'18 preview: organic plus inorganic growth
2nd Aug 2018 7:00 am RNS Notice of Interim Results
4th Jul 2018 7:00 am RNS Appointment of CFO
25th Jun 2018 7:00 am RNS HTA License granted and UK distribution Agreement
21st Jun 2018 7:10 am RNS TRX BioSurgery wins GPO Supplier Horizon Award
18th Jun 2018 7:00 am RNS Issue of Equity
24th May 2018 12:12 pm RNS Result of AGM
2nd May 2018 7:00 am RNS TRX BioSurgery GPO agreement with Premier, Inc.
27th Apr 2018 7:00 am RNS Posting of Annual Report and Notice of AGM
24th Apr 2018 7:00 am RNS DermaPure manufacturing at CellRight Facility
19th Apr 2018 3:29 pm RNS Holding(s) in Company
5th Apr 2018 7:17 am EQS Hardman & Co Research: Tissue Regenix (TRX): CellRight hits the right note
26th Mar 2018 7:00 am RNS Annual results for period ended 31 December 2017
16th Mar 2018 3:40 pm RNS Publication of Financial Results
8th Mar 2018 7:15 am RNS Hardman & Co: Full-year 2017 - what to look for
6th Mar 2018 7:00 am RNS Long term distribution agreement with Arthrex, Inc
26th Feb 2018 7:00 am RNS Notice of Results
26th Feb 2018 7:00 am RNS Launch of BioSurgery and new distributor agreement
2nd Feb 2018 7:00 am RNS Issue of Equity
22nd Dec 2017 9:30 am RNS Issue of Equity
1st Dec 2017 7:00 am RNS Directorate Change
1st Dec 2017 7:00 am RNS Issue of Equity
2nd Nov 2017 7:00 am RNS Appointment of CEO
18th Oct 2017 7:00 am RNS Directorate Change
11th Oct 2017 7:15 am RNS Hardman Research: Dual revenue stream growth
FTSE 100 Latest
Value8,809.74
Change53.53